Crystalys Therapeutics closes $130M Series B to fund gout drug trials
Go back to Crystalys Therapeutics closes $130M Series B to fund gout drug trials| Fabien Corp (NASDAQ: FBIO) | Delayed: 2.50 -0.01 (0.4%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $2.51 | 52 Week High | $4.66 | |||
| Open | $2.51 | 52 Week Low | $2.01 | |||
| Day High | $2.52 | P/E | N/A | |||
| Day Low | $2.48 | EPS | $0.00 | |||
| Volume | 38,245 | |||||

